Jessica Breu | Head, Investor Relations and Communications |
Daniel Vitt | Chief Executive Officer and President |
Glenn Whaley | Chief Financial Officer |
Hella Kohlhof | Chief Scientific Officer |
Andreas Argyrides | Wedbush |
Yasmeen Rahimi | Piper Sandler |
Matt Kaplan | Ladenburg |
Michael Kratky | SVB Securities |
Good morning, everybody and welcome to Immunic’s Second Quarter 2022 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic. I will also be the moderator on today’s call.
Speaking on the call are Dr. Daniel Vitt, our Chief Executive Officer and President as well as Glenn Whaley, our Chief Financial Officer.